ASA404: update on drug development

被引：17

作者：

Rehman, Farah ^{[1
]}

Rustin, Gordon ^{[1
]}

机构：

[1] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England

来源：

EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2008年 / 17卷 / 10期

关键词：

antivascular agents; ASA404; tumour blood vessel; tumour vasculature; vascular disrupting agents; vascular targeting;

D O I：

10.1517/13543784.17.10.1547

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Background: Interrupting tumour blood flow and delivery of nutrients to cause tumour death is the aim of antiangiogenic and vascular disrupting agents (VDAs). ASA404 is the first VDA to enter Phase III trials.. Objective: We review the preclinical and clinical data on this interesting agent and consider its place in modern therapeutics. Methods: PubMed database was searched for 'ASA404', 'AS1404', 'DMXAA', 'vascular disrupting agents', 'ASA404 clinical trials', 'AS1404 clinical trials', 'DMXAA clinical trials'. Results/conclusions: ASA404 is a tumour VDA that is well tolerated and has shown promise in the treatment of NSCLC in combination with paclitaxel and carboplatin. A confirmatory Phase III trial is currently ongoing.

引用

页码：1547 / 1551

页数：5

共 44 条

[1]

[Anonymous], 2006, AM J CANCER, DOI DOI 10.2165/00024669-200605030-00002

[2] Antivascular therapy of cancer: DMXAA [J].

Baguley, BC .

LANCET ONCOLOGY, 2003, 4 (03) :141-148

[3] COMPARISON OF THE EFFECTS OF FLAVONE ACETIC-ACID, FOSTRIECIN, HOMOHARRINGTONINE AND TUMOR NECROSIS FACTOR-ALPHA ON COLON-38 TUMORS IN MICE [J].

BAGULEY, BC ;

CALVELEY, SB ;

CROWE, KK ;

FRAY, LM ;

OROURKE, SA ;

SMITH, GP .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :263-269

[4] REDUCTION OF TUMOR BLOOD-FLOW BY FLAVONE ACETIC-ACID - A POSSIBLE COMPONENT OF THERAPY [J].

BIBBY, MC ;

DOUBLE, JA ;

LOADMAN, PM ;

DUKE, CV .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (03) :216-222

[5]

Bloemendal HJ, 1999, EUR J CLIN INVEST, V29, P802

[6]

Chaplin DJ, 1999, BRIT J CANCER, V80, P57

[7]

Chaplin DJ, 1999, ANTICANCER RES, V19, P189

[8]

CHING LM, 1994, CANCER RES, V54, P870

[9] Relationship between tumour enclothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice [J].

Ching, LM ;

Zwain, S ;

Baguley, CC .

BRITISH JOURNAL OF CANCER, 2004, 90 (04) :906-910

[10] Induction of endothelial cell apoptosis by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid [J].

Ching, LM ;

Cao, Z ;

Kieda, C ;

Zwain, S ;

Jameson, MB ;

Baguley, BC .

BRITISH JOURNAL OF CANCER, 2002, 86 (12) :1937-1942

← 1 2 3 4 5 →